122 related articles for article (PubMed ID: 16298964)
1. Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein.
Le LP; Li J; Ternovoi VV; Siegal GP; Curiel DT
J Gen Virol; 2005 Dec; 86(Pt 12):3201-3208. PubMed ID: 16298964
[TBL] [Abstract][Full Text] [Related]
2. In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection.
Ugai H; Wang M; Le LP; Matthews DA; Yamamoto M; Curiel DT
J Mol Biol; 2010 Jan; 395(1):55-78. PubMed ID: 19853616
[TBL] [Abstract][Full Text] [Related]
3. Fluorescently labeled adenovirus with pIX-EGFP for vector detection.
Le LP; Everts M; Dmitriev IP; Davydova JG; Yamamoto M; Curiel DT
Mol Imaging; 2004 Apr; 3(2):105-16. PubMed ID: 15296675
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
5. Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells.
Le LP; Rivera AA; Glasgow JN; Ternovoi VV; Wu H; Wang M; Smith BF; Siegal GP; Curiel DT
Gene Ther; 2006 Mar; 13(5):389-99. PubMed ID: 16292351
[TBL] [Abstract][Full Text] [Related]
6. Production and purification of non replicative canine adenovirus type 2 derived vectors.
Szelechowski M; Bergeron C; Gonzalez-Dunia D; Klonjkowski B
J Vis Exp; 2013 Dec; (82):50833. PubMed ID: 24326926
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge.
Fischer L; Tronel JP; Pardo-David C; Tanner P; Colombet G; Minke J; Audonnet JC
Vaccine; 2002 Oct; 20(29-30):3485-97. PubMed ID: 12297394
[TBL] [Abstract][Full Text] [Related]
8. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.
Li J; Le L; Sibley DA; Mathis JM; Curiel DT
Virology; 2005 Aug; 338(2):247-58. PubMed ID: 15996701
[TBL] [Abstract][Full Text] [Related]
9. Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP.
Meulenbroek RA; Sargent KL; Lunde J; Jasmin BJ; Parks RJ
Mol Ther; 2004 Apr; 9(4):617-24. PubMed ID: 15093192
[TBL] [Abstract][Full Text] [Related]
10. Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX.
Zakhartchouk A; Connors W; van Kessel A; Tikoo SK
Virology; 2004 Mar; 320(2):291-300. PubMed ID: 15016551
[TBL] [Abstract][Full Text] [Related]
11. [Construction and identification of recombinant canine adenovirus type 2 expressing exogenous rabies glycoprotein (Rgp)].
Zhao ZP; Xia XZ; Hu RL; Xie ZJ; Yan F; Huang G; Yang ST
Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):335-9. PubMed ID: 17552245
[TBL] [Abstract][Full Text] [Related]
12. A simplified system for generating recombinant E3-deleted canine adenovirus-2.
Yu Z; Jiang Q; Liu J; Guo D; Quan C; Li B; Qu L
Plasmid; 2015 Jan; 77():1-6. PubMed ID: 25450764
[TBL] [Abstract][Full Text] [Related]
13. Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.
Vellinga J; de Vrij J; Myhre S; Uil T; Martineau P; Lindholm L; Hoeben RC
Gene Ther; 2007 Apr; 14(8):664-70. PubMed ID: 17268536
[TBL] [Abstract][Full Text] [Related]
14. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
15. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.
Poulin KL; Lanthier RM; Smith AC; Christou C; Risco Quiroz M; Powell KL; O'Meara RW; Kothary R; Lorimer IA; Parks RJ
J Virol; 2010 Oct; 84(19):10074-86. PubMed ID: 20631131
[TBL] [Abstract][Full Text] [Related]
16. Chromatography purification of canine adenoviral vectors.
Segura MM; Puig M; Monfar M; Chillón M
Hum Gene Ther Methods; 2012 Jun; 23(3):182-97. PubMed ID: 22799886
[TBL] [Abstract][Full Text] [Related]
17. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.
Matthews QL; Sibley DA; Wu H; Li J; Stoff-Khalili MA; Waehler R; Mathis JM; Curiel DT
Mol Imaging; 2006; 5(4):510-9. PubMed ID: 17150163
[TBL] [Abstract][Full Text] [Related]
18. Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX.
Tang Y; Le LP; Matthews QL; Han T; Wu H; Curiel DT
Virology; 2008 Aug; 377(2):391-400. PubMed ID: 18570971
[TBL] [Abstract][Full Text] [Related]
19. Trafficking and propagation of canine adenovirus vectors lacking a known integrin-interacting motif.
Chillon M; Kremer EJ
Hum Gene Ther; 2001 Sep; 12(14):1815-23. PubMed ID: 11560774
[TBL] [Abstract][Full Text] [Related]
20. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
